
Shares in the company lost about half their value in Friday trading after use of the test wasn’t associated with a statistically significant reduction in late-stage cancer diagnoses.

Shares in the company lost about half their value in Friday trading after use of the test wasn’t associated with a statistically significant reduction in late-stage cancer diagnoses.
Autologous therapies need data-driven manufacturing and supply chain mastery. Integrated CDMOs combine both functions to…
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…
Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, threatening to create disruptions to patient care.…
Clinical development is still shaped by a stubborn asymmetry: only around one in ten drug candidates that enter human testing…
News Flatiron Health has launched six new hematology datasets built using AI and large language models (LLMs), unlocking longitudinal clinical…
Valued at $1.25 billion, the deal expands BioNTech’s cancer drug portfolio and heads off royalty costs it could have owed…
Sign in to your account